These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 9618513

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Investigation of Batten disease with the yeast Saccharomyces cerevisiae.
    Pearce DA, Sherman F.
    Mol Genet Metab; 1999 Apr; 66(4):314-9. PubMed ID: 10191120
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in the juvenile form of Batten disease.
    Croopnick JB, Choi HC, Mueller DM.
    Biochem Biophys Res Commun; 1998 Sep 18; 250(2):335-41. PubMed ID: 9753630
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. btn1, the Schizosaccharomyces pombe homologue of the human Batten disease gene CLN3, regulates vacuole homeostasis.
    Gachet Y, Codlin S, Hyams JS, Mole SE.
    J Cell Sci; 2005 Dec 01; 118(Pt 23):5525-36. PubMed ID: 16291725
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease.
    Kim Y, Ramirez-Montealegre D, Pearce DA.
    Proc Natl Acad Sci U S A; 2003 Dec 23; 100(26):15458-62. PubMed ID: 14660799
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein.
    Mitchison HM, Taschner PE, Kremmidiotis G, Callen DF, Doggett NA, Lerner TJ, Janes RB, Wallace BA, Munroe PB, O'Rawe AM, Gardiner RM, Mole SE.
    Neuropediatrics; 1997 Feb 23; 28(1):12-4. PubMed ID: 9151311
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide signaling is disrupted in the yeast model for Batten disease.
    Osório NS, Carvalho A, Almeida AJ, Padilla-Lopez S, Leão C, Laranjinha J, Ludovico P, Pearce DA, Rodrigues F.
    Mol Biol Cell; 2007 Jul 23; 18(7):2755-67. PubMed ID: 17475770
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A model for Batten disease protein CLN3: functional implications from homology and mutations.
    Janes RW, Munroe PB, Mitchison HM, Gardiner RM, Mole SE, Wallace BA.
    FEBS Lett; 1996 Dec 09; 399(1-2):75-7. PubMed ID: 8980123
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.